ncRNA name
hsa-miR-191
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
RXRA
Cancer name
Prostate Cancer
Cancer site
Prostate
Treatment type
Radiotherapy
Impact of wild-type ncRNA on radiotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
That miR-191 promotes prostate cancer survival after radiotherapy, and highlights retinoids as a potential option to improve radiotherapy response.
Tissue resource
human prostate carcinoma cell lines DU145
human prostate carcinoma cell lines PC3
human prostate carcinoma cell lines DU145
human prostate carcinoma cell lines PC3
Experiment
qRT-PCR,Western blot
Institute
American Type Culture Collection
American Type Culture Collection
American Type Culture Collection
Country
USA
United States
Continent
North American
North Amercian